| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.6M | -40.8% |
| R&D Expense | $11.9M | +115.7% |
| SG&A Expense | $8.9M | +13.4% |
| Operating Income | -$17.2M | -118.3% |
| Pre-tax Income | -$15.6M | -114.8% |
| Income Tax | -$720K | -199.5% |
| Net Income | -$14.9M | -86.3% |
| EPS (Basic) | -$0.98 | -24.1% |
| EPS (Diluted) | -$0.98 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.3M | +17.5% |
| Current Assets | $44.3M | +7.6% |
| Total Assets | $44.3M | +7.5% |
| Current Liabilities | $3.8M | -24.3% |
| Total Liabilities | $4.8M | -15.2% |
| Stockholders' Equity | $39.6M | +11.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.3M | +8.0% |
| Investing Cash Flow | -$25K | +95.4% |
| Financing Cash Flow | $16.0M | -58.3% |
| -24.1% |